Svetlana Paskas

Svetlana Paskas

UNVERIFIED PROFILE

Are you Svetlana Paskas?   Register this Author

Register author
Svetlana Paskas

Svetlana Paskas

Publications by authors named "Svetlana Paskas"

Are you Svetlana Paskas?   Register this Author

14Publications

206Reads

28Profile Views

Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo.

Invest New Drugs 2019 Oct 1;37(5):1014-1028. Epub 2019 Feb 1.

Department of Immunology, Institute for Biological Research "Sinisa Stankovic", Belgrade University, Belgrade, Serbia.

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10637-019-00733-3
Publisher Site
http://dx.doi.org/10.1007/s10637-019-00733-3DOI Listing
October 2019

Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma.

Mol Carcinog 2019 Aug 17;58(8):1362-1375. Epub 2019 Apr 17.

Department of Immunology, Institute for Biological Research "Siniša Stanković", Belgrade University, Belgrade, Serbia.

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/mc.23020
Publisher Site
http://dx.doi.org/10.1002/mc.23020DOI Listing
August 2019

Carboranyl Analogues of Celecoxib with Potent Cytostatic Activity against Human Melanoma and Colon Cancer Cell Lines.

ChemMedChem 2019 Feb 23;14(3):315-321. Epub 2019 Jan 23.

Institut für Anorganische Chemie, Universität Leipzig, Johannisallee 29, 04103, Leipzig, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cmdc.201800685DOI Listing
February 2019

Inverse expression of caveolin-1 and EGFR in thyroid cancer patients.

Hum Pathol 2017 03 4;61:164-172. Epub 2016 Nov 4.

Institute for the Application of Nuclear Energy-INEP, Department for Endocrinology and Radioimmunology, University of Belgrade, 11080 Belgrade, Serbia. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2016.10.020DOI Listing
March 2017

Malignant risk stratification of thyroid FNA specimens with indeterminate cytology based on molecular testing.

Cancer Cytopathol 2015 Aug 27;123(8):471-9. Epub 2015 Apr 27.

Institute for the Application of Nuclear Energy, Department of Endocrinology and Radioimmunology, University of Belgrade, Belgrade, Serbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncy.21554DOI Listing
August 2015

Strong expression of HBME-1 associates with high-risk clinicopathological factors of papillary thyroid carcinoma.

Pathol Oncol Res 2015 Jul 11;21(3):735-42. Epub 2015 Jan 11.

Institute for the Application of Nuclear Energy - INEP, University of Belgrade, Banatska 31b, P.O.Box 46, 11080, Zemun, Belgrade, Serbia,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s12253-014-9883-6DOI Listing
July 2015

Enhanced activation of matrix metalloproteinase-9 correlates with the degree of papillary thyroid carcinoma infiltration.

Croat Med J 2014 Apr;55(2):128-37

Svetlana Savin, Institute for the Application of Nuclear Energy - INEP, University of Belgrade, Banatska 31b, 11080 Zemun - Belgrade, Serbia,

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4009713PMC
http://dx.doi.org/10.3325/cmj.2014.55.128DOI Listing
April 2014

Caveolin-1 expression in papillary thyroid carcinoma: correlation with clinicopathological parameters and BRAF mutation status.

Otolaryngol Head Neck Surg 2014 Feb 19;150(2):201-9. Epub 2013 Nov 19.

Institute for the Application of Nuclear Energy-INEP, Department for Endocrinology and Immunoradiology, Belgrade, Serbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/0194599813512781DOI Listing
February 2014

Caveolin-1 expression in thyroid neoplasia spectrum: comparison of two commercial antibodies.

Dis Markers 2012 ;33(6):321-31

Institute for the Application of Nuclear Energy - INEP, Department for Endocrinology and Immunoradiology, University of Belgrade, Serbia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3233/DMA-2012-00934DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810771PMC
May 2013

Human cytomegalovirus increases HUVEC sensitivity to thrombin and modulates expression of thrombin receptors.

J Thromb Thrombolysis 2010 Aug;30(2):164-71

Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, Helmholtzstr 20, 89081 Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11239-010-0447-7DOI Listing
August 2010

Mature dendritic cells express functional thrombin receptors triggering chemotaxis and CCL18/pulmonary and activation-regulated chemokine induction.

J Immunol 2008 Jul;181(2):1215-23

Institute of Pharmacology of Natural Products and Clinical Pharmacology, Ulm University, Ulm, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.181.2.1215DOI Listing
July 2008